NCT00306072 Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1/PHASE2
NCT00301392 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Status COMPLETED Phase PHASE4
NCT00298428 Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE) Status COMPLETED Phase NA
NCT00298129 Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease Status COMPLETED Phase N/A
NCT00296374 Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease Status COMPLETED Phase PHASE2
NCT00295555 Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy Status COMPLETED Phase PHASE4
NCT00288678 A Prospective Study on Diabetes Management Through an Integrated Delivery System Status COMPLETED Phase PHASE3
NCT00287066 A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition Status TERMINATED Phase PHASE3
NCT00286598 Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet Status COMPLETED Phase PHASE1
NCT00286494 Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00286468 Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00286455 Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00286442 Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00286429 Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes. Status COMPLETED Phase PHASE3
NCT00280085 The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI. Status TERMINATED Phase NA
NCT00279266 Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy Status WITHDRAWN Phase NA
NCT00277732 Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial Status COMPLETED Phase NA